{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T12:29:21Z","timestamp":1770726561762,"version":"3.49.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T00:00:00Z","timestamp":1768262400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T00:00:00Z","timestamp":1770595200000},"content-version":"vor","delay-in-days":27,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Social Development Foundation of Zhenjiang","award":["SH2023022"],"award-info":[{"award-number":["SH2023022"]}]},{"name":"the Social Development Foundation of Zhenjiang","award":["SH2024001"],"award-info":[{"award-number":["SH2024001"]}]},{"name":"the Social Development Foundation of Zhenjiang","award":["SH2024031"],"award-info":[{"award-number":["SH2024031"]}]},{"name":"the \u201cJinshan Doctor\u201d Medical Field Talent Project"},{"name":"the Research Fund Project of Zhenjiang First People\u2019s Hospital","award":["YP2023001"],"award-info":[{"award-number":["YP2023001"]}]},{"name":"the Research Fund Project of Zhenjiang First People\u2019s Hospital","award":["Y2023007-S"],"award-info":[{"award-number":["Y2023007-S"]}]},{"name":"the Research Fund Project of Zhenjiang First People\u2019s Hospital","award":["Y2022010"],"award-info":[{"award-number":["Y2022010"]}]},{"name":"the Youth Medical Talents Project of \u201cKe Jiao Qiang Wei\u201d project of Jiangsu province","award":["QNRC2016449"],"award-info":[{"award-number":["QNRC2016449"]}]},{"name":"the Zhenjiang Clinical Research Center of Hematology","award":["SS2018009"],"award-info":[{"award-number":["SS2018009"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-026-04390-w","type":"journal-article","created":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T16:14:40Z","timestamp":1768320880000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Abnormal PLK2 expression is associated with specific subtypes and may help risk stratification in acute myeloid leukemia"],"prefix":"10.1007","volume":"17","author":[{"given":"Qin","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zijun","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tingting","family":"Du","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dongming","family":"Yao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haoxi","family":"Ni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,13]]},"reference":[{"key":"4390_CR1","doi-asserted-by":"publisher","first-page":"16010","DOI":"10.1038\/nrdp.2016.10","volume":"2","author":"A Khwaja","year":"2016","unstructured":"Khwaja A, Bjorkholm M, Gale RE, et al. Acute myeloid leukaemia. Nat Rev Dis Primers. 2016;2:16010.","journal-title":"Nat Rev Dis Primers"},{"issue":"10","key":"4390_CR2","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1007\/s00277-016-2666-2","volume":"95","author":"MA Sanz","year":"2016","unstructured":"Sanz MA, Iacoboni G, Montesinos P, et al. Emerging strategies for the treatment of older patients with acute myeloid leukemia. Ann Hematol. 2016;95(10):1583\u201393.","journal-title":"Ann Hematol"},{"issue":"3","key":"4390_CR3","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1053\/beha.2001.0152","volume":"14","author":"D Grimwade","year":"2001","unstructured":"Grimwade D. The clinical significance of cytogenetic abnormalities in acute myeloid leukaemia. Best Pract Res Clin Haematol. 2001;14(3):497\u2013529.","journal-title":"Best Pract Res Clin Haematol"},{"issue":"13","key":"4390_CR4","doi-asserted-by":"publisher","first-page":"4325","DOI":"10.1182\/blood-2002-03-0772","volume":"100","author":"JC Byrd","year":"2002","unstructured":"Byrd JC, Mr\u00f3zek K, Dodge RK, et al. Cancer and leukemia group B (CALGB 8461). Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de Novo acute myeloid leukemia: results from cancer and leukemia group B (CALGB 8461). Blood. 2002;100(13):4325\u201336.","journal-title":"Blood"},{"issue":"1","key":"4390_CR5","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/s12935-023-02937-3","volume":"23","author":"X Bao","year":"2023","unstructured":"Bao X, Chi J, Zhu Y, et al. High FAAP24 expression reveals poor prognosis and an immunosuppressive microenvironment shaping in AML. Cancer Cell Int. 2023;23(1):117.","journal-title":"Cancer Cell Int"},{"issue":"1","key":"4390_CR6","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1186\/s13148-022-01373-w","volume":"14","author":"Y Gu","year":"2022","unstructured":"Gu Y, Xu ZJ, Zhou JD, et al. SLC22A3 methylation-mediated gene Silencing predicts adverse prognosis in acute myeloid leukemia. Clin Epigenetics. 2022;14(1):162.","journal-title":"Clin Epigenetics"},{"issue":"1","key":"4390_CR7","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1007\/s12672-023-00826-9","volume":"14","author":"XY Chen","year":"2023","unstructured":"Chen XY, Wen XM, Zhao W, et al. ALOX5AP is a new prognostic indicator in acute myeloid leukemia. Discov Oncol. 2023;14(1):210.","journal-title":"Discov Oncol"},{"issue":"24","key":"4390_CR8","doi-asserted-by":"publisher","first-page":"3777","DOI":"10.1101\/gad.12.24.3777","volume":"12","author":"DM Glover","year":"1998","unstructured":"Glover DM, Hagan IM, Tavares AA. Polo-like kinases: a team that plays throughout mitosis. Genes Dev. 1998;12(24):3777\u201387.","journal-title":"Genes Dev"},{"issue":"7","key":"4390_CR9","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1038\/nrm3819","volume":"15","author":"S Zitouni","year":"2014","unstructured":"Zitouni S, Nabais C, Jana SC, et al. Polo-like kinases: structural variations lead to multiple functions. Nat Rev Mol Cell Biol. 2014;15(7):433\u201352.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"6","key":"4390_CR10","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1016\/S0955-0674(98)80121-X","volume":"10","author":"EA Nigg","year":"1998","unstructured":"Nigg EA. Polo-like kinases: positive regulators of cell division from start to finish. Curr Opin Cell Biol. 1998;10(6):776\u201383.","journal-title":"Curr Opin Cell Biol"},{"issue":"3","key":"4390_CR11","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1158\/2767-9764.CRC-21-0106","volume":"1","author":"Y Gao","year":"2021","unstructured":"Gao Y, Kabotyanski EB, Shepherd JH, et al. Tumor suppressor PLK2 May serve as a biomarker in triple-negative breast cancer for improved response to PLK1 therapeutics. Cancer Res Commun. 2021;1(3):178\u201393.","journal-title":"Cancer Res Commun"},{"issue":"3","key":"4390_CR12","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1002\/hep.23467","volume":"51","author":"R Pellegrino","year":"2010","unstructured":"Pellegrino R, Calvisi DF, Ladu S, et al. Oncogenic and tumor suppressive roles of polo-like kinases in human hepatocellular carcinoma. Hepatology. 2010;51(3):857\u201368.","journal-title":"Hepatology"},{"issue":"1","key":"4390_CR13","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1182\/blood-2005-03-1194","volume":"107","author":"N Syed","year":"2006","unstructured":"Syed N, Smith P, Sullivan A, et al. Transcriptional Silencing of Polo-like kinase 2 (SNK\/PLK2) is a frequent event in B-cell malignancies. Blood. 2006;107(1):250\u20136.","journal-title":"Blood"},{"key":"4390_CR14","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1186\/1471-2407-14-678","volume":"14","author":"Y Tian","year":"2014","unstructured":"Tian Y, Fu S, Qiu GB, et al. MicroRNA-27a promotes proliferation and suppresses apoptosis by targeting PLK2 in laryngeal carcinoma. BMC Cancer. 2014;14:678.","journal-title":"BMC Cancer"},{"issue":"4","key":"4390_CR15","doi-asserted-by":"publisher","first-page":"3033","DOI":"10.3892\/mmr.2014.3077","volume":"11","author":"LY Liu","year":"2015","unstructured":"Liu LY, Wang W, Zhao LY, et al. Silencing of polo-like kinase 2 increases cell proliferation and decreases apoptosis in SGC-7901 gastric cancer cells. Mol Med Rep. 2015;11(4):3033\u20138.","journal-title":"Mol Med Rep"},{"issue":"10","key":"4390_CR16","doi-asserted-by":"publisher","first-page":"2447","DOI":"10.1007\/s00432-020-03288-6","volume":"146","author":"Y Zeng","year":"2020","unstructured":"Zeng Y, Li N, Liu W, et al. Analyses of expressions and prognostic values of Polo-like kinases in non-small cell lung cancer. J Cancer Res Clin Oncol. 2020;146(10):2447\u201360.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"5","key":"4390_CR17","first-page":"1401","volume":"52","author":"Y Xie","year":"2018","unstructured":"Xie Y, Liu Y, Li Q, et al. Polo-like kinase 2 promotes chemoresistance and predicts limited survival benefit from adjuvant chemotherapy in colorectal cancer. Int J Oncol. 2018;52(5):1401\u201314.","journal-title":"Int J Oncol"},{"issue":"2","key":"4390_CR18","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.canlet.2016.07.004","volume":"380","author":"B Ou","year":"2016","unstructured":"Ou B, Zhao J, Guan S, et al. Plk2 promotes tumor growth and inhibits apoptosis by targeting Fbxw7\/Cyclin E in colorectal cancer. Cancer Lett. 2016;380(2):457\u201366.","journal-title":"Cancer Lett"},{"key":"4390_CR19","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1016\/j.biopha.2018.04.190","volume":"103","author":"T Han","year":"2018","unstructured":"Han T, Lin J, Wang Y, et al. Forkhead box D1 promotes proliferation and suppresses apoptosis via regulating polo-like kinase 2 in colorectal cancer. Biomed Pharmacother. 2018;103:1369\u201375.","journal-title":"Biomed Pharmacother"},{"issue":"12","key":"4390_CR20","doi-asserted-by":"publisher","first-page":"3471","DOI":"10.1111\/jcmm.17361","volume":"26","author":"Y Zong","year":"2022","unstructured":"Zong Y, Miao Y, Li W, et al. Combination of FOXD1 and Plk2: A novel biomarker for predicting unfavourable prognosis of colorectal cancer. J Cell Mol Med. 2022;26(12):3471\u201382.","journal-title":"J Cell Mol Med"},{"issue":"40","key":"4390_CR21","doi-asserted-by":"publisher","first-page":"15535","DOI":"10.1073\/pnas.0808266105","volume":"105","author":"Z Li","year":"2008","unstructured":"Li Z, Lu J, Sun M, et al. Distinct MicroRNA expression profiles in acute myeloid leukemia with common translocations. Proc Natl Acad Sci U S A. 2008;105(40):15535\u201340.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"4390_CR22","doi-asserted-by":"publisher","first-page":"6154","DOI":"10.1038\/s41467-021-26420-7","volume":"12","author":"L Zhang","year":"2021","unstructured":"Zhang L, Nguyen LXT, Chen YC, et al. Targeting miR-126 in inv(16) acute myeloid leukemia inhibits leukemia development and leukemia stem cell maintenance. Nat Commun. 2021;12(1):6154.","journal-title":"Nat Commun"},{"issue":"9","key":"4390_CR23","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1007\/s00277-011-1193-4","volume":"90","author":"L Benetatos","year":"2011","unstructured":"Benetatos L, Dasoula A, Hatzimichael E, et al. Polo-like kinase 2 (SNK\/PLK2) is a novel epigenetically regulated gene in acute myeloid leukemia and myelodysplastic syndromes: genetic and epigenetic interactions. Ann Hematol. 2011;90(9):1037\u201345.","journal-title":"Ann Hematol"},{"issue":"8","key":"4390_CR24","doi-asserted-by":"publisher","first-page":"2478","DOI":"10.1158\/1535-7163.MCT-08-1132","volume":"8","author":"SA Vasudevan","year":"2009","unstructured":"Vasudevan SA, Shang X, Chang S, et al. Neuroblastoma-derived secretory protein is a novel secreted factor overexpressed in neuroblastoma. Mol Cancer Ther. 2009;8(8):2478\u201389.","journal-title":"Mol Cancer Ther"},{"issue":"11","key":"4390_CR25","doi-asserted-by":"publisher","first-page":"6347","DOI":"10.21037\/tcr-24-2159","volume":"13","author":"J Qu","year":"2024","unstructured":"Qu J, Cheng X, Liu M, et al. CTNND2 gene expression in melanoma tissues and its effects on the malignant biological functions of melanoma cells. Transl Cancer Res. 2024;13(11):6347\u201363.","journal-title":"Transl Cancer Res"},{"key":"4390_CR26","doi-asserted-by":"publisher","first-page":"750083","DOI":"10.3389\/fmolb.2022.750083","volume":"9","author":"Q Zhang","year":"2022","unstructured":"Zhang Q, Pan J, Nie H, et al. Dishevelled-Associated activator of morphogenesis 2 (DAAM2) predicts the Immuno-Hot phenotype in pancreatic adenocarcinoma. Front Mol Biosci. 2022;9:750083.","journal-title":"Front Mol Biosci"},{"issue":"7","key":"4390_CR27","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.3109\/10428194.2011.566391","volume":"52","author":"S Nagel","year":"2011","unstructured":"Nagel S, Venturini L, Przybylski GK, et al. Activation of Paired-homeobox gene PITX1 by del(5)(q31) in T-cell acute lymphoblastic leukemia. Leuk Lymphoma. 2011;52(7):1348\u201359.","journal-title":"Leuk Lymphoma"},{"issue":"4","key":"4390_CR28","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1002\/eji.1830230428","volume":"23","author":"M Delhase","year":"1993","unstructured":"Delhase M, Vergani P, Malur A, et al. The transcription factor Pit-1\/GHF-1 is expressed in Hemopoietic and lymphoid tissues. Eur J Immunol. 1993;23(4):951\u20135.","journal-title":"Eur J Immunol"},{"key":"4390_CR29","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/1476-4598-12-5","volume":"12","author":"S Lisboa","year":"2013","unstructured":"Lisboa S, Cerveira N, Bizarro S, et al. POU1F1 is a novel fusion partner of NUP98 in acute myeloid leukemia with t(3;11)(p11;p15). Mol Cancer. 2013;12:5.","journal-title":"Mol Cancer"},{"issue":"4","key":"4390_CR30","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1038\/leu.2009.293","volume":"24","author":"TL Gu","year":"2010","unstructured":"Gu TL, Cherry J, Tucker M, et al. Identification of activated Tnk1 kinase in hodgkin\u2019s lymphoma. Leukemia. 2010;24(4):861\u20135.","journal-title":"Leukemia"},{"issue":"1","key":"4390_CR31","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1186\/s12967-024-05861-w","volume":"22","author":"Y Luo","year":"2024","unstructured":"Luo Y, Shentu J, Xu H, et al. Innovative pan-tumor target strategy for CAR-T therapy: cancer-specific exons as novel targets for pediatric solid and brain tumors. J Transl Med. 2024;22(1):1019.","journal-title":"J Transl Med"},{"issue":"5","key":"4390_CR32","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1002\/mc.23700","volume":"63","author":"X Zhou","year":"2024","unstructured":"Zhou X, Dong S, Zhou Y, et al. EMX2 inhibits clear cell renal cell carcinoma progress via modulating Akt\/FOXO3a pathway. Mol Carcinog. 2024;63(5):951\u201361.","journal-title":"Mol Carcinog"},{"issue":"4","key":"4390_CR33","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.4103\/jcrt.jcrt_558_24","volume":"20","author":"Z Chai","year":"2024","unstructured":"Chai Z, Zhu C, Wang X, et al. PADI3 inhibits epithelial-mesenchymal transition by targeting CKS1-induced signal transduction in colon cancer. J Cancer Res Ther. 2024;20(4):1323\u201333.","journal-title":"J Cancer Res Ther"},{"issue":"4","key":"4390_CR34","doi-asserted-by":"publisher","first-page":"918","DOI":"10.3390\/biomedicines12040918","volume":"12","author":"X Chen","year":"2024","unstructured":"Chen X, Poetsch A. The role of Cdo1 in ferroptosis and apoptosis in cancer. Biomedicines. 2024;12(4):918.","journal-title":"Biomedicines"},{"issue":"20","key":"4390_CR35","doi-asserted-by":"publisher","first-page":"8788","DOI":"10.1039\/D5SC01211B","volume":"16","author":"W Liu","year":"2025","unstructured":"Liu W, Ma ZC, Zhang S, et al. Direct single-nucleotide resolution sequencing of DNA 5-methylcytosine using engineered DNA methyltransferase-mediated CMD-seq. Chem Sci. 2025;16(20):8788\u201399.","journal-title":"Chem Sci"},{"issue":"16\u201318","key":"4390_CR36","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1089\/ars.2024.0882","volume":"42","author":"B Fan","year":"2025","unstructured":"Fan B, Wang L, Hu T, et al. Exosomal miR-196a-5p secreted by bone marrow mesenchymal stem cells inhibits ferroptosis and promotes drug resistance of acute myeloid leukemia. Antioxid Redox Signal. 2025;42(16\u201318):933\u201353.","journal-title":"Antioxid Redox Signal"},{"issue":"2","key":"4390_CR37","doi-asserted-by":"publisher","first-page":"89","DOI":"10.3727\/096504016X14597766487753","volume":"24","author":"Y Lou","year":"2016","unstructured":"Lou Y, Liu L, Zhan L, et al. miR-187-5p regulates cell growth and apoptosis in acute lymphoblastic leukemia via DKK2. Oncol Res. 2016;24(2):89\u201397.","journal-title":"Oncol Res"},{"issue":"8","key":"4390_CR38","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1016\/j.humpath.2014.04.005","volume":"45","author":"E Duregon","year":"2014","unstructured":"Duregon E, Rapa I, Votta A, et al. MicroRNA expression patterns in adrenocortical carcinoma variants and clinical pathologic correlations. Hum Pathol. 2014;45(8):1555\u201362.","journal-title":"Hum Pathol"},{"issue":"5","key":"4390_CR39","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1007\/s00438-018-1447-0","volume":"293","author":"S Xiao","year":"2018","unstructured":"Xiao S, Zhang M, Liu C, et al. MiR-514 attenuates proliferation and increases chemoresistance by targeting ATP binding cassette subfamily in ovarian cancer. Mol Genet Genomics. 2018;293(5):1159\u201367.","journal-title":"Mol Genet Genomics"},{"issue":"6","key":"4390_CR40","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/j.amjms.2023.02.014","volume":"365","author":"C Wu","year":"2023","unstructured":"Wu C, Yang J, Lin X, et al. miR-508-5p serves as an anti-oncogene by targeting S100A16 to regulate AKT signaling and epithelial-mesenchymal transition process in lung adenocarcinoma cells. Am J Med Sci. 2023;365(6):520\u201331.","journal-title":"Am J Med Sci"},{"key":"4390_CR41","doi-asserted-by":"publisher","first-page":"6782046","DOI":"10.1155\/2020\/6782046","volume":"2020","author":"B He","year":"2020","unstructured":"He B, Xu J, Tian Y, et al. Gene coexpression network and module analysis across 52 human tissues. Biomed Res Int. 2020;2020:6782046.","journal-title":"Biomed Res Int"},{"issue":"3","key":"4390_CR42","doi-asserted-by":"publisher","first-page":"e9849","DOI":"10.1371\/journal.pone.0009849","volume":"5","author":"A Krause","year":"2010","unstructured":"Krause A, Hoffmann I. Polo-like kinase 2-dependent phosphorylation of NPM\/B23 on Serine 4 triggers centriole duplication. PLoS ONE. 2010;5(3):e9849.","journal-title":"PLoS ONE"},{"key":"4390_CR43","doi-asserted-by":"publisher","first-page":"e7974","DOI":"10.7717\/peerj.7974","volume":"7","author":"X Xia","year":"2019","unstructured":"Xia X, Cao F, Yuan X, et al. Low expression or hypermethylation of PLK2 might predict favorable prognosis for patients with glioblastoma multiforme. PeerJ. 2019;7:e7974.","journal-title":"PeerJ"},{"issue":"5","key":"4390_CR44","doi-asserted-by":"publisher","first-page":"2320","DOI":"10.18632\/aging.203940","volume":"14","author":"Y Ding","year":"2022","unstructured":"Ding Y, Liu H, Zhang C, et al. Polo-like kinases as potential targets and PLK2 as a novel biomarker for the prognosis of human glioblastoma. Aging. 2022;14(5):2320\u201334.","journal-title":"Aging"},{"key":"4390_CR45","doi-asserted-by":"publisher","first-page":"119084","DOI":"10.1016\/j.lfs.2021.119084","volume":"270","author":"F Cao","year":"2021","unstructured":"Cao F, Xia X, Fan Y, et al. Knocking down of Polo-like kinase 2 inhibits cell proliferation and induced cell apoptosis in human glioma cells. Life Sci. 2021;270:119084.","journal-title":"Life Sci"},{"issue":"1","key":"4390_CR46","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s13045-024-01553-6","volume":"17","author":"KJ Archer","year":"2024","unstructured":"Archer KJ, Fu H, Mr\u00f3zek K, et al. Identifying long-term survivors and those at higher or lower risk of relapse among patients with cytogenetically normal acute myeloid leukemia using a high-dimensional mixture cure model. J Hematol Oncol. 2024;17(1):28.","journal-title":"J Hematol Oncol"},{"issue":"7","key":"4390_CR47","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1016\/j.stem.2024.04.021","volume":"31","author":"S Li","year":"2024","unstructured":"Li S, Ling S, Wang D, et al. Modified lentiviral globin gene therapy for pediatric \u03b20\/\u03b20 transfusion-dependent \u03b2-thalassemia: A single-center, single-arm pilot trial. Cell Stem Cell. 2024;31(7):961\u2013e9738.","journal-title":"Cell Stem Cell"},{"issue":"4","key":"4390_CR48","doi-asserted-by":"publisher","first-page":"362","DOI":"10.14744\/ejmo.2023.35138","volume":"7","author":"A Zahran","year":"2023","unstructured":"Zahran A, Zahran ZA, Gamal D, et al. Disturbed expression of memory T-Cell subsets could alter the outcomes in adult acute myeloid leukemia. EJMO. 2023;7(4):362\u201370.","journal-title":"EJMO"},{"key":"4390_CR49","doi-asserted-by":"publisher","first-page":"113392","DOI":"10.1016\/j.intimp.2024.113392","volume":"144","author":"DY Sun","year":"2025","unstructured":"Sun DY, Hu YJ, Li X, et al. Unlocking the full potential of memory T cells in adoptive T cell therapy for hematologic malignancies. Int Immunopharmacol. 2025;144:113392.","journal-title":"Int Immunopharmacol"},{"issue":"9","key":"4390_CR50","doi-asserted-by":"publisher","first-page":"3317","DOI":"10.1158\/0008-5472.CAN-10-2048","volume":"71","author":"N Syed","year":"2011","unstructured":"Syed N, Coley HM, Sehouli J, Koensgen D, Mustea A, Szlosarek P, McNeish I, Blagden SP, Schmid P, Lovell DP, Hatzimichael E, et al. Polo-like kinase Plk2 is an epigenetic determinant of chemosensitivity and clinical outcomes in ovarian cancer. Cancer Res. 2011;71(9):3317\u201327.","journal-title":"Cancer Res"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-026-04390-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-026-04390-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-026-04390-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T16:04:18Z","timestamp":1770653058000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-026-04390-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,13]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4390"],"URL":"https:\/\/doi.org\/10.1007\/s12672-026-04390-w","relation":{},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,13]]},"assertion":[{"value":"14 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the Declaration of Helsinki and approved by the Ethics Committee of the Affiliated People\u2019s Hospital of Jiangsu University (Approval No: K-20250081-W). Informed consent was obtained from all individuals included in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"267"}}